I switched beta blockers a few days ago. Four or five, maybe. Nothing dramatic. No crisis. No near-miss. But my fingers are warm again, for the first time in months. And I’m sleeping better than I have in a long time. Those aren’t headline outcomes. They’re not the things medicine congratulates itself for. They are just noticeable. Modern medicine is very good at preventing death. It’s less good at noticing when life becomes slightly smaller.

When I was put on metoprolol, no one mentioned that cold fingers might come with it. Or that my skin might feel oddly chilled even in a comfortable room. Metoprolol is a perfectly good beta blocker. But like many in its class, it leans toward peripheral vasoconstriction, tightening the tiny vessels in the hands and feet. It wasn’t negligence. It wasn’t ignorance. It just wasn’t important enough to talk about.

We talked about the big things:

• Heart rate.
• Blood pressure.
• Risk reduction.
• Outcomes that fit on a graph.

So I adapted. Extra layers. Hands that didn’t feel like mine. A quiet assumption that this was simply the price of doing business. That’s what modern medicine teaches you to do: Triage your own discomfort. Patients learn to self-triage what parts of their life are worth mentioning. You get a short visit. You prioritize survival. You leave the “minor” things unspoken, not because they don’t matter, but because there’s no room for them.

Later, almost accidentally, I learned about nebivolol. A beta blocker that still slows the heart but uniquely promotes nitric oxide-mediated vasodilation instead of tightening the peripheral vessels. Less peripheral constriction. Less cold. I switched. And without ceremony, my body noticed. Warm hands on the steering wheel. Fingers that didn’t feel like someone else’s. Sleep that arrived without effort.

That’s the part that stayed with me. Not the pharmacology. Not the cleverness of the molecule. But how easily months of daily discomfort could have been avoided if there had been time to talk about something that didn’t threaten my life. For years, as a psychiatrist, I met new patients with medication lists that made me wince. Three antidepressants. Two mood stabilizers. A benzodiazepine. Something for sleep. Something else for the side effects. I used to wonder, honestly, how anyone let this happen.

I understand now. It happened one reasonable visit at a time. Each decision made sense in isolation:

• Let’s just help you sleep.
• You’re stable, let’s not rock the boat.
• We don’t have time to taper today.
• We’ll revisit this later.

Later rarely comes. The system rewards adding medications. It quietly punishes taking them away. Stopping a medication takes time. Explaining why takes even longer. And if something goes wrong later, subtraction is harder to defend than addition. So the list grows. And patients learn, very quickly, what kinds of suffering are worth mentioning, and which ones are not. You save your time for the big things. You tolerate the rest.

That’s why I’ve been feeling a little like Rip Van Winkle. Not because I’m nostalgic. Not because I’m romanticizing the past. But because I practiced medicine in a way that insulated me from what health care has become. I saw two people an hour. Three, the past few years when everyone was doing well. I got to know them over years. Little things mattered, because memory mattered. Side effects weren’t trivia. They were clues.

Now, sitting on the other side of the desk, I feel the wall. Not a cruel wall. Not an uncaring one. A procedural wall. The system isn’t designed for back-and-forth. It’s designed for problem-solving. For decisions that can be documented cleanly and defended later. There’s very little space for a sentence like this: “This isn’t dangerous, but it’s making my life smaller.” Those conversations take time. They require continuity. They require someone who remembers what you were like before.

My point isn’t that medicine is broken. It’s that it has narrowed its field of vision. We talk, rightly, about the things that might kill us. But we’ve lost much of our ability to talk about the things that quietly erode daily life. Cold fingers. Restless sleep. Low-grade discomfort that never triggers alarm, but never leaves either. They don’t show up on outcome measures. They don’t justify long visits. And yet, they matter.

I didn’t realize how much they mattered until they were gone. And that, more than anything, is what surprised me. Not the side effect. Not the solution. But how little room there was, in modern medicine, to notice the difference. Modern medicine saved my life long before this visit. But this week it reminded me of something smaller, and in its own way, just as important. Warm fingers. And the realization that the little things matter more than we remember.

Jeffrey Junig is a psychiatrist and addiction medicine specialist with a longstanding interest in the intersection of neuroscience, clinical care, and the systems that shape modern medicine. He is affiliated with the Medical College of Wisconsin and has spent much of his career working with patients affected by substance use disorders.

Dr. Junig has written about addiction treatment and clinical practice for many years, including his long-running Suboxone Talk Zone, which began in 2007 and now continues on Substack. His essays explore medicine, neuroscience, and the often unexpected ways in which health care systems influence patient care and physician decision-making.

He publishes ongoing commentary and essays on Unscripted Practice. A full list of his academic publications and professional background is available on his curriculum vitae.